EMS Healthcare has broadened its endoscopy offer with the launch of Trilogy+, a state-of-the-art mobile endoscopy facility which will provide NHS trusts with additional scoping capacity in light of recent changes to bowel cancer screening recommendations.
The National Screening Committee now recommends bowel cancer screenings to begin at the age of 50 – lowered from 60, a move which has caused an immediate surge in demand for endoscopy services.
In April 2020, the Faster Diagnosis Standard is also set to come into effect, with NHS trusts expected to give a definitive diagnosis on cancer within 28 days of referral.
And the Trilogy+ facility will prove a key resource for NHS trusts going forward, as the number of procedures rises substantially.
Designed and built to the latest JAG guidelines; the self-contained unit can be deployed on the hospital site or in a community setting, enabling endoscopists to perform a range of diagnostic and therapeutic procedures, with the capacity to deliver +24 JAG points per day.
With Trilogy+, we have redefined standards within the mobile healthcare industry
The layout of Trilogy+ is optimised throughout to provide trusts with a complete endoscopy solution, from procedure through to decontamination.
Utilising state-of-the-art decontamination equipment, provided by Cantel UK; the unit can reprocess up to six scopes per hour, ensuring the minimum amount of scopes are required to deliver a cost-effective and efficient service.
And, to ensure everything keeps running, the unit is backed by a Gold Planned Preventative Maintenance (PPM) contract.
Other features include a procedure room fitted with a fully-integrated piped medical gas system, with CO2, Entonox, oxygen and suction ( HTM 02-01 compliant), a private consultation room, three recovery bays, two seated recovery areas, a nurse station, reception area, bathroom facilities, and a spacious decontamination suite.
The inclusion of a dedicated decontamination suite ensures Trilogy+ includes all features of EMS Healthcare’s market-leading decontamination unit: Quest+.
Keith Austin, chief executive at EMS Healthcare, said: “Each year almost 42,000 people are diagnosed with bowel cancer, making it the fourth most-common cancer in the UK.
“The lowering of the recommended screening age in England and Wales has therefore been a really-positive step forward, as it has the potential to save thousands of lives over the coming years.
The decontamination unit can process up to six scopes an hour
“To ensure this move is a success, it’s vital that NHS trusts have the resources to deal with a sharp increase in demand on endoscopy services, especially with the Faster Diagnosis Standard just around the corner.
“We simply cannot have patients facing delays to receive potentially life-saving diagnostic tests.”
He added: “With Trilogy+, we have redefined standards within the mobile healthcare industry.
“The unit matches the latest facilities found onsite at hospitals, and, crucially, prioritises the patient experience.
“It will provide trusts which much-needed additional scoping capacity in light of the updated screening requirements, and we’re really looking forward to announcing our first NHS trust partner in the coming months.”
